Kansas Venture Capital

Konza Valley Capital, Inc. (KVCI), formerly known as Kansas Venture Capital, Inc., is a private equity and venture capital firm headquartered in Overland Park, Kansas. Established in 1977, the firm operates as a licensed Small Business Investment Company (SBIC) providing equity and mezzanine financing to lower-middle-market companies, primarily in the Midwest. While maintaining a broad industry focus, KVCI has significant experience in the healthcare and life sciences sectors, notably acquiring the bioanalytical division of AAIPharma to form KCAS Bio. The firm typically invests in profitable companies with annual revenues between $10 million and $100 million, seeking long-term capital appreciation. KVCI is recognized as one of the oldest and most established venture capital firms in the Kansas investment community.